Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

ALAMEDA, Calif.–(BUSINESS WIRE)– #CRISPR–Company will highlight developments enabled by its CRISPR by Design™ approach to engineer novel in vivo genetic medicines
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks